Castle Biosciences
IPOInnovative Molecular Prognostic and Diagnostic Tests
Public · FRIENDSWOOD, United States · $50.5M raised
- Headquarters
- FRIENDSWOOD, Texas
- Employees
- 501–1000
- Business Model
- B2B
- Website
- castlebiosciences.com
- Total Funding
- $50.5M
- Last Round
- $12.0M Series FApr 2019
- Rounds
- 6
- Type
- Public
About
Castle Biosciences is a leading diagnostics company delivering advanced molecular diagnostics and prognostic tests, including genomic profiling for melanoma and other skin cancers, to guide patient care and improve outcomes.
Summary
Castle Biosciences is a Healthcare company based in FRIENDSWOOD, United States. It has raised $50.5M in total across 6 rounds, most recently a $12.0M Series F round in Apr 2019. Investors include American Cancer Society BrightEdge Fund, Industry Ventures and HealthQuest Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2019
Sign up to see all 7 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
